India bans 328 drugs in setback for pharma firms
By Reuters
September 14, 2018
NEW DELHI: The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but the ban has been cheered by health activists worried about growing antibiotic resistance due to the misuse of medicines.
The Indian government had in 2016 banned about 350 such drugs, referred to as fixed-dose combinations (FDCs), but the industry mounted various legal challenges that prompted the Supreme Court to call for a review by an advisory board.
The health ministry on Wednesday said the board had found there was "no therapeutic justification for the ingredients contained in 328 FDCs and that these FDCs may involve risk to human beings".
-
Australia To Launch First High-speed Bullet Train After 50-years Delay -
Meghan Markle Turns To Desperate Bids & Her Kids Are Her ‘saving Grace’: Here’s What They’ll Do -
King Charles Gives A Nod To Sister Anne's Latest Royal Visit -
Christian Bale Shares Rare Views On Celebrity Culture Urging Fans Not To Meet Him In Person -
Ariana Grande To Skip Actor Awards Despite Major Nomination -
North Carolina Teen Accused Of Killing Sister, Injuring Brother In Deadly Attack -
Ryan Gosling Releases Witty 'Project Hail Mary' Ad With Sweet Reference To Eva Mendes -
Teyana Taylor Reveals What Lured Her Back To Music After Earning Fame In Acting Industry -
Prince William Shows He's Ready To Lead The Monarchy Amid Andrew Scandal -
Lux Pascal Gushes Over Role In Tom Ford's 'Cry To Heaven': 'I Just Wanted To Be Part Of This Picture' -
Near-blind Refugee Found Dead In Buffalo After Release By US Border Patrol -
Firm Steps In Forcing Andrew’s Hand: ‘Can No Longer Keep A Promise' -
Kenyan Man Accused Of Recruiting Men To Fight In Ukraine -
'The Wrong Paris' Star Veronica Long Shares What New Crime Series 'Blue Skies' Is About -
King Charles Remains Immersed In Work Amid Andrew Scrutiny -
Bobby J. Brown's Passing Adds To Growing List Of Celebrity Deaths In 2026